Tunnah’s musings: Rare diseases hold key to future of drug d...

The lessons that can be learned for the future of drug development from the collaboration and innovation in this space.

Patient-centricity and pharma: where are we now?

How should the industry define patient-centricity, and how should progress be measured?

ESMO review: advances in immunotherapy, EMA dialogue and pa...

QuintilesIMS’s Cristina Oliva talks to pharmaphorum about her personal highlights from this year’s congress.

Measuring the cost of diabetes

Can patient education programmes start reducing the burden?

The 2016 'Inspiring Hope' Ideathon - Day Two Coverage and re...

Urgent need for clarity as government suspends pharmacy cut ...

But reprieve may last only until plans have been reviewed.